Literature DB >> 3881819

Extramedullary haemopoiesis after bone marrow transplantation.

R Arnold, W Calvo, B Heymer, T Schmeiser, H Heimpel, B Kubanek.   

Abstract

44 patients underwent bone marrow transplantation (BMT) for treatment of severe aplastic anaemia or haematological malignancies. During their post-transplant phase all patients had erythroblasts and granulocytic precursors in their peripheral blood. 15 patients died between day +6 and +346 after BMT and autopsies were performed. The sections of all 15 patients revealed extramedullary haemopoiesis in the spleen. Extramedullary haemopoiesis in the liver was found only in those patients who died early (between d +6 and d +21 after BMT). Medullary haemopoiesis, normally only occurring in the vertebral body, was also observed in the shaft of the femur. The present data show that after BMT all tissues with a haemopoietic matrix in ontogenesis can be repopulated with haemopoiesis in the early phase of reconstitution, possibly to compensate for the haemopoietic insufficiency after conditioning therapy. The expansion of haemopoiesis in the later period of up to 1 year after BMT, remains to be explained.

Entities:  

Mesh:

Year:  1985        PMID: 3881819     DOI: 10.1111/j.1600-0609.1985.tb00736.x

Source DB:  PubMed          Journal:  Scand J Haematol        ISSN: 0036-553X


  3 in total

1.  Early reconstitution of haematopoiesis after allogeneic bone marrow transplantation: a prospective histopathological study of bone marrow biopsy specimens.

Authors:  H van den Berg; P M Kluin; J M Vossen
Journal:  J Clin Pathol       Date:  1990-05       Impact factor: 3.411

2.  Splenic haematopoiesis in patients with cirrhosis of the liver.

Authors:  K D Palitzsch; S Falk; H Müller; H J Stutte
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

Review 3.  Mechanisms of erythrocyte development and regeneration: implications for regenerative medicine and beyond.

Authors:  Emery H Bresnick; Kyle J Hewitt; Charu Mehta; Sunduz Keles; Robert F Paulson; Kirby D Johnson
Journal:  Development       Date:  2018-01-10       Impact factor: 6.868

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.